Buffered Lidocaine Syringes at Brooke Army Medical Center, JBSA Ft. Sam Houston, TX
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Medical Readiness Contracting Office – West (MRCO-West), part of the Department of the Army, is issuing a Sources Sought notice to identify potential sources for Buffered Lidocaine Syringes at Brooke Army Medical Center (BAMC), JBSA Ft. Sam Houston, TX. This market research aims to inform the acquisition strategy for approximately 6,000 syringes annually. Responses are due May 14, 2026.
Scope of Work
The requirement is for approximately 6,000 Buffered Lidocaine Syringes annually, specifically 1% buffered with 8.4% sodium Bicarbonate 10ml/syringe. These will be supplied to Brooke Army Medical Center.
Contract & Timeline
- Type: Sources Sought / Market Research
- Duration: Anticipated Period of Performance (PoP) of one (1) twelve-month base period and four (4) twelve-month option years, from October 1, 2026, to September 30, 2031.
- Set-Aside: Not determined; may be set-aside for small businesses (in full or in part) or procured through full and open competition. All small business categories will be considered.
- NAICS: 339112, Surgical and Medical Instrument Manufacturing (Size Standard: 1,000 employees)
- Response Due: May 14, 2026, 11:00 AM Central Time
- Published: May 7, 2026
Evaluation
Responses will be used by the Government to formulate its acquisition strategy, including potential small business set-asides. This is for informational purposes only and does not constitute a solicitation or commitment to award a contract.
Additional Notes
Interested offerors must submit tailored capability statements electronically to Mr. Patrick Thielemann (patrick.a.thielemann.civ@health.mil) and Ms. Salameya Paulouskaya (salameya.paulouskaya2.civ@health.mil). The subject line of the email and all documents should reference "Buffered Lidocaine Syringes". Submissions should include firm name, POC, phone, email, UEI, CAGE, small business status/certifications, and an opinion on the suitability of NAICS code 339112. No telephone inquiries will be accepted.